Literature DB >> 18028484

SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients.

Barbara-Ann Guinn, Lars Bullinger, N Shaun B Thomas, Ken I Mills, Jochen Greiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18028484     DOI： 10.1111/j.1365-2141.2007.06892.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

2.  Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.

Authors:  Pu Li; Xuehua Chen; Liping Su; Chenglong Li; Qiaoming Zhi; Beiqin Yu; Hong Sheng; Junqing Wang; Runhua Feng; Qu Cai; Jianfang Li; Yingyan Yu; Min Yan; Bingya Liu; Zhenggang Zhu
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

3.  Msd1/SSX2IP-dependent microtubule anchorage ensures spindle orientation and primary cilia formation.

Authors:  Akiko Hori; Chiho Ikebe; Masazumi Tada; Takashi Toda
Journal:  EMBO Rep       Date:  2014-01-07       Impact factor: 8.807

4.  SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma.

Authors:  Pu Li; Ying Lin; Yu Zhang; Zhenggang Zhu; Keke Huo
Journal:  J Transl Med       Date:  2013-03-01       Impact factor: 5.531

Review 5.  New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.

Authors:  Stephanie Jordaens; Leah Cooksey; Laurie Freire Boullosa; Viggo Van Tendeloo; Evelien Smits; Ken I Mills; Kim H Orchard; Barbara-Ann Guinn
Journal:  Cancer Immunol Immunother       Date:  2020-01-22       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.